![The Tendyne transcatheter mitral valve replacement system for the treatment of mitral regurgitation | Future Cardiology The Tendyne transcatheter mitral valve replacement system for the treatment of mitral regurgitation | Future Cardiology](https://www.futuremedicine.com/cms/10.2217/fca-2018-0090/asset/images/medium/figure1.gif)
The Tendyne transcatheter mitral valve replacement system for the treatment of mitral regurgitation | Future Cardiology
![Neo-Left Ventricular Outflow Tract Modification With Alcohol Septal Ablation Before Tendyne Transcatheter Mitral Valve Replacement | JACC: Cardiovascular Interventions Neo-Left Ventricular Outflow Tract Modification With Alcohol Septal Ablation Before Tendyne Transcatheter Mitral Valve Replacement | JACC: Cardiovascular Interventions](https://www.jacc.org/cms/asset/12f72fc6-57ea-467a-b387-716abc718319/gr1.jpg)
Neo-Left Ventricular Outflow Tract Modification With Alcohol Septal Ablation Before Tendyne Transcatheter Mitral Valve Replacement | JACC: Cardiovascular Interventions
![Left Ventricular Remodeling After Transcatheter Mitral Valve Replacement With Tendyne: New Insights From Computed Tomography | JACC: Cardiovascular Interventions Left Ventricular Remodeling After Transcatheter Mitral Valve Replacement With Tendyne: New Insights From Computed Tomography | JACC: Cardiovascular Interventions](https://www.jacc.org/cms/asset/e99309cc-4ec9-4ace-b14b-cc47f13c5f16/fx1.jpg)
Left Ventricular Remodeling After Transcatheter Mitral Valve Replacement With Tendyne: New Insights From Computed Tomography | JACC: Cardiovascular Interventions
![Minneapolis Heart Institute Continues Early Feasibility Trial With Tendyne Device for Smaller Hearts | DAIC Minneapolis Heart Institute Continues Early Feasibility Trial With Tendyne Device for Smaller Hearts | DAIC](http://www.dicardiology.com/sites/default/files/X0000_Abbott_Tendyne_Mitral_valve_Patent_Office_illustration_0.jpg)
Minneapolis Heart Institute Continues Early Feasibility Trial With Tendyne Device for Smaller Hearts | DAIC
![Tendyne: A revolutionary technology for mitral valve replacement | Royal Brompton & Harefield Hospitals Specialist Care Tendyne: A revolutionary technology for mitral valve replacement | Royal Brompton & Harefield Hospitals Specialist Care](https://www.rbhh-specialistcare.co.uk/sites/default/files/styles/news_image_aspect_switcher/public/news_image/2021-06/3_0.png?itok=yTmN0lQv)
Tendyne: A revolutionary technology for mitral valve replacement | Royal Brompton & Harefield Hospitals Specialist Care
![Transcatheter Mitral Valve Replacement: Insights From Early Clinical Experience and Future Challenges - ScienceDirect Transcatheter Mitral Valve Replacement: Insights From Early Clinical Experience and Future Challenges - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109717359697-fx1.jpg)
Transcatheter Mitral Valve Replacement: Insights From Early Clinical Experience and Future Challenges - ScienceDirect
![Abbott's Tendyne becomes first transcatheter mitral valve implantation device to receive CE mark - Medical Technology | Issue 25 | March 2020 Abbott's Tendyne becomes first transcatheter mitral valve implantation device to receive CE mark - Medical Technology | Issue 25 | March 2020](https://medical-technology.nridigital.com/medical-technology/medical_technology_mar20/abbotts_tendyne_becomes_first_transcatheter_mitral_valve_implantation_device/815045/__screenshot.jpg)
Abbott's Tendyne becomes first transcatheter mitral valve implantation device to receive CE mark - Medical Technology | Issue 25 | March 2020
![Abbott on Twitter: "Late-breaking data presented at #EuroPCR showed positive clinical outcomes and reduction of mitral regurgitation at 30 days for our investigational Tendyne mitral valve replacement device. #TMVR Learn more: https://t.co/usAib8vezQ Abbott on Twitter: "Late-breaking data presented at #EuroPCR showed positive clinical outcomes and reduction of mitral regurgitation at 30 days for our investigational Tendyne mitral valve replacement device. #TMVR Learn more: https://t.co/usAib8vezQ](https://pbs.twimg.com/media/Dd65TvSV4AATkzS.jpg)
Abbott on Twitter: "Late-breaking data presented at #EuroPCR showed positive clinical outcomes and reduction of mitral regurgitation at 30 days for our investigational Tendyne mitral valve replacement device. #TMVR Learn more: https://t.co/usAib8vezQ
![TRANSCATHETER MITRAL VALVE IMPLANTATION FOR SEVERE MITRAL REGURGITATION: THE TENDYNE GLOBAL FEASIBILITY TRIAL 1 YEAR OUTCOMES David WM Muller, MBBS, - ppt download TRANSCATHETER MITRAL VALVE IMPLANTATION FOR SEVERE MITRAL REGURGITATION: THE TENDYNE GLOBAL FEASIBILITY TRIAL 1 YEAR OUTCOMES David WM Muller, MBBS, - ppt download](https://slideplayer.com/slide/13843330/85/images/3/Tendyne+Transcatheter+Mitral+Valve.jpg)
TRANSCATHETER MITRAL VALVE IMPLANTATION FOR SEVERE MITRAL REGURGITATION: THE TENDYNE GLOBAL FEASIBILITY TRIAL 1 YEAR OUTCOMES David WM Muller, MBBS, - ppt download
![JCM | Free Full-Text | Transcatheter Mitral Valve Repair or Replacement: Competitive or Complementary? JCM | Free Full-Text | Transcatheter Mitral Valve Repair or Replacement: Competitive or Complementary?](https://www.mdpi.com/jcm/jcm-11-03377/article_deploy/html/images/jcm-11-03377-g002a.png)